On October 17, 2025, the FDA approved tezepelumab (Tezspire; AstraZeneca and Amgen) as an add-on maintenance treatment for adults and adolescents aged 12 years and older with inadequately controlled ...

IDWeek 2025 heads to Atlanta October 19–22 with cutting-edge sessions on AMR, AI, vaccines, HIV, pediatrics, and global health challenges. The infectious diseases community will gather in Atlanta from ...

In part 3 of this 7-part Special Report, the discussion turns to the importance of diagnostic stewardship, with Denise Heaney, PhD, underscoring how FDA-cleared assays—ranging from at-home sample ...

The clinical report replaces a 2010 report, as food allergy impacts up to 10% of children, with anaphylaxis estimated to occur in 1 in 15 schools per year. Authors note that accurate diagnosis is the ...

Richard Auchus, MD, PhD, discusses how crinecerfont is improving CAH care and easing the transition from pediatric to adult management. Since its FDA approval on December 13, 2024, crinecerfont ...

As team sports ramp up this fall, pediatricians can expect the return of a familiar question from parents: “What should my child eat before the big game?” Sports nutrition is not just a modified ...

The indication approved is for children aged 6 years and older who weigh at least 45 kg (99 lbs) for the preventive treatment of episodic migraine. On August 5, 2025, the FDA approved ...

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place. Want to stay up to date with pediatric news? Subscribe to the Contemporary ...

Pelthos Therapeutics has launched berdazimer (Zelsuvmi) topical gel, 10.3%, for the treatment of molluscum contagiosum in adults and pediatric patients aged 1 year and older, according to a company ...

Though the decision will not meet the June 17, 2025, target date, the federal agency anticipates a decision within approximately 4 weeks. The FDA will not meet a prescription drug user fee act (PDUFA) ...

RFK Jr. stated he "couldn't be more pleased" to announce that COVID-19 vaccination among healthy children and pregnant women has been removed from CDC's immunization schedule. "I couldn't be more ...

The approved indication now includes children down to 6 weeks of age to protect against invasive meningococcal disease via serogroups A, C, W, and Y. On May 23, 2025, the FDA approved an expanded ...